NIH-funded research R01 grant

Identifying a biomarker to predict type 2 diabetes after gestational diabetes

Official title: Biomarker of Pancreatic B-cell Loss Predicting Progression to Type 2 Diabetes After Gestational Diabetes

Funded at Lsu Pennington Biomedical Research Ctr · NIH-11009491 · Data updated 2026-11-12

This study is looking at how a specific type of DNA related to insulin can help predict if women who had gestational diabetes are at risk of developing type 2 diabetes later on, by checking their blood samples and health over time.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLsu Pennington Biomedical Research Ctr
NIH-funded
Lab location1 site (Baton Rouge, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2027
Funding year2025
Award (this year)$600,945
NIH project number5R01DK132011-03
Project IDNIH-11009491 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women who have had gestational diabetes and are within the postpartum period.

Less likely to help

Patients who have not experienced gestational diabetes or are not within the postpartum timeframe may not benefit from this research.

What this research studies

This research investigates how unmethylated insulin gene DNA can predict the risk of developing type 2 diabetes in women who have previously experienced gestational diabetes. By analyzing blood samples from two large cohorts of women, one in the U.S. and another in China, the study aims to track changes in this biomarker from 6-12 weeks postpartum and several years later. Participants will undergo glucose tolerance tests and other laboratory assessments to monitor their health over time.

Why it matters

Potential benefit: If successful, this research could lead to early identification of women at risk for type 2 diabetes, allowing for timely interventions.

How similar studies have gone: Previous studies have shown promise in using biomarkers to predict diabetes risk, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Lsu Pennington Biomedical Research Ctr
    Baton Rouge, United States
    Active

Researchers

  • Principal investigator: Hu, Gang — Lsu Pennington Biomedical Research Ctr
  • Study coordinator: Hu, Gang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.